PMC9204359_01
Illustrations of the case reports 1 (A-F) and 2 (G, H). Abscesses and draining fistulae of the right armpit at baseline (A), decrease of inflammation and suppuration 3 months after initiation of adalimumab (B), wide excision of remaining non draining fistulae 1 year after initiation of adalimumab (C). Draining fistulae of the left armpit at baseline (D), decrease of inflammation and suppuration 3 months after initiation of adalimumab (E), wide excision of remaining non draining fistulae 1 year after initiation of adalimumab (C). Initial Hurley 2 lesion of case report 2 (G). Recurrence after limited excision of the lesion and direct suture (H).
fimmu-13-883811-g001.jpg
PMC9204359_02_fimmu-13-883811-g001.jpg
f1
Several courses of oral antibiotics and limited excisions procedures were unsuccessfully performed until HS diagnosis (Figures 1G, H).
PMC9204359_02
Illustrations of the case reports 1 (A-F) and 2 (G, H). Abscesses and draining fistulae of the right armpit at baseline (A), decrease of inflammation and suppuration 3 months after initiation of adalimumab (B), wide excision of remaining non draining fistulae 1 year after initiation of adalimumab (C). Draining fistulae of the left armpit at baseline (D), decrease of inflammation and suppuration 3 months after initiation of adalimumab (E), wide excision of remaining non draining fistulae 1 year after initiation of adalimumab (C). Initial Hurley 2 lesion of case report 2 (G). Recurrence after limited excision of the lesion and direct suture (H).
fimmu-13-883811-g001.jpg
PMC9204359_02_fimmu-13-883811-g001.jpg
f1
Several courses of oral antibiotics and limited excisions procedures were unsuccessfully performed until HS diagnosis (Figures 1G, H).